[Objective] This study tries to discover knowledge from the high-level evidence-based literature on diseases indexed by PubMed, aiming to provide reference for clinical diagnosis, treatment, as well as routine prevention and control of diseases. [Methods] We proposed a diseases knowledge discovery model based on SPO predications with the semantic extraction tool SemRep. Then we selected the diabetes-related literature to evaluate this model, and discovered knowledge based on SPO visualization and clinical knowledge. [Results] We obtained 1 258 SPO predications and 16 semantic relationships, which identified diabetes-related genes, common complications, as well as detection and treatment methods. [Limitations] We only examined our model with publicly accessible literature. More research is needed to include knowledge bases and electronic medical records. [Conclusions] The disease knowledge discovery model based on SPO predication could identify the biomedical knowledge from literature, which provides potential research hypotheses and ideas for biomedical researchers.
National Library of Medicine. PubMed Overview[EB/OL].[2021-05-04]. https://pubmed.ncbi.nlm.nih.gov/about/ .
[2]
Pyysalo S, Baker S, Ali I, et al. LION LBD: A Literature-Based Discovery System for Cancer Biology[J]. Bioinformatics, 2019, 35(9):1553-1561.
doi: 10.1093/bioinformatics/bty845
pmid: 30304355
( Wei Ling, Hu Zhengyin, Pang Hongshen, et al. Study on Knowledge Discovery Based on “Subject-Predication-Object” Predications: A Case Study of Induced Pluripotent Stem Cells[J]. Digital Library Forum, 2017(9):28-34.)
[4]
Liu Y, Bill R, Fiszman M, et al. Using SemRep to Label Semantic Relations Extracted from Clinical Text[J]. Proceedings of the AMIA Annual Fall Symposium, 2012: 587-595.
[5]
World Health Organization. Noncommunicable Diseases[EB/OL].(2018-06-1). [2021-05-06]. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases .
[6]
Harding J L, Pavkov M E, Magliano D J, et al. Global Trends in Diabetes Complications: A Review of Current Evidence[J]. Diabetologia, 2019, 62(1):3-16.
doi: 10.1007/s00125-018-4711-2
(National Health Commission. Healthy China Action(2019-2030)[EB/OL].(2019-07-15). [2021-05-06]. http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm. .
[8]
Gopalakrishnan V, Jha K, Jin W, et al. A Survey on Literature Based Discovery Approaches in Biomedical Domain[J]. Journal of Biomedical Informatics, 2019, 93:103141.
doi: S1532-0464(19)30059-0
pmid: 30857950
( Dai Bing, Hu Zhengyin. Review of Studies on Literature-Based Discovery[J]. Data Analysis and Knowledge Discovery, 2021, 5(4):1-12.)
[10]
Swanson D R, Smalheiser N R. An Interactive System for Finding Complementary Literatures: A Stimulus to Scientific Discovery[J]. Artificial Intelligence, 1997, 91(2):183-203.
doi: 10.1016/S0004-3702(97)00008-8
[11]
Cohen T, Widdows D, Stephan C, et al. Predicting High-throughput Screening Results with Scalable Literature-based Discovery Methods[J]. CPT: Pharmacometrics & Systems Pharmacology, 2014, 3(10):e140.
( He Dan, Jiang Miao, Zheng Guang, et al. Exploring Relationship Among Symptom, Pattern and Medication Regularityof Hypertension Based on Text Mining Technology[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2014, 20(19):214-216.)
( Hu Zhengyin, Liu Leilei, Dai Bing, et al. Discovering Subject Knowledge in Life and Medical Sciences with Knowledge Graph[J]. Data Analysis and Knowledge Discovery, 2020, 4(11):1-14.)
[14]
Xu B, Shi X, Zhao Z, et al. Leveraging Biomedical Resources in Bi-LSTM for Drug Drug Interaction Extraction[J]. IEEE Access, 2018, 6:33432-33439.
doi: 10.1109/ACCESS.2018.2845840
( Li Zhiheng, Gui Yingyi, Yang Zhihao, et al. Chemical-Induced Disease Relation Extraction Based on Biomedical Literature[J]. Journal of Computer Research and Development, 2018, 55(1):198-206.)
( Li Xiaoying, Li Junlian, Li Danya. Research on the Unified Medical Language System and Its Application to Knowledge Discovery[J].Digital Library Forum, 2019(9):24-29.)
[17]
Fiszman M, Rindflesch T C, Kilicoglu H. Summarizing Drug Information in Medline Citations[J]. Proceedings of the AMIA Annual Fall Symposium, 2006: 254-258.
[18]
Kilicoglu H, Fiszman M, Rodriguez R, et al. Semantic MEDLINE: A Web Application for Managing the Results of PubMed Searches[C]// Proceedings of the 3rd International Symposium on Semantic Mining in Biomedicine. 2008: 69-76.
[19]
Zhang H, Fiszman M, Shin D, et al. Clustering Cliques for Graph-based Summarization of the Biomedical Research Literature[J]. BMC Bioinformatics, 2013, 14(1):Article No. 182.
doi: 10.1186/1471-2105-14-182
( Yan Lei, Liu Chunhe, Guan Jing, et al. The Development of Statistics Mining System Based on Result Analysis by Application of SemRep[J]. Journal of Medical Informatics, 2013, 34(4):31-34.)
( Wang Xue, Yang Xuemei, Li Peixin, et al. Contradiction Knowledge Discovery of Drugs Based on Semantic Model[J]. Journal of Intelligence, 2020, 39(7):159-165.)
[22]
Fiszman M, Rindflesch T C, Kilicoglu H. Abstraction Summarization for Managing the Biomedical Research Literature[C]// Proceedings of the HLT/NAACL 2004 Workshop on Computational Lexical Semantics. USA: Association for Computational Linguistics, 2004: 76-83.
[23]
Lundkvist P, Pereira MJ, Kamble PG, et al. Glucagon Levels During Short-Term SGLT2 Inhibition are Largely Regulated by Glucose Changes in Patients with Type 2 Diabetes[J]. Journal of Clinical Endocrinology and Metabolism, 2019, 104(1):193-201.
doi: 10.1210/jc.2018-00969
[24]
Stomby A, Otten J, Ryberg M, et al. Diet-induced Weight Loss Alters Hepatic Glucocorticoid Metabolism in Type 2 Diabetes Mellitus[J]. European Journal of Endocrinology, 2020, 182(4):447-457.
doi: 10.1530/EJE-19-0901
[25]
Furuhashi M, Hiramitsu S, Mita T, et al. Reduction of Serum FABP4 Level by Sitagliptin, a DPP-4 Inhibitor, in Patients with Type 2 Diabetes Mellitus[J]. Journal of Lipid Research, 2015, 56(12):2372-2380.
doi: 10.1194/jlr.M059469
pmid: 26467280
[26]
殷雨晨. 糖尿病并发症(Ⅰ)[J]. 中国伤残医学, 2020, 28(23):I0003.
[26]
(Yin Yuchen. Diabetes Complications (Ⅰ)[J]. Chinese Journal of Trauma and Disability Medicine, 2020, 28(23):I0003.)
[27]
Henriksen M M, Andersen H U, Thorsteinsson B, et al. Asymptomatic Hypoglycaemia in Type 1 Diabetes: Incidence and Risk Factors[J]. Diabetic Medicine, 2019, 36(1):62-69.
doi: 10.1111/dme.13848
( Wang Yongsheng, Yang Lixia, Cheng Tao, et al. Pathogenic Mechanism of Inflammation and TCM Intervention of Diabetic Nephropathy[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2018, 24(2):200-207.)
[30]
Weng J P, Bi Y. Epidemiological Status of Chronic Diabetic Complications in China[J]. Chinese Medical Journal, 2015, 128(24):3267-3269.
doi: 10.4103/0366-6999.171350
( Wang Chao. The Influence of Overweight, Obesity and Main Risk Factors on the Incidence of Diabetes in Chinese Adults[D]. Beijing: Peking Union Medical College, 2014.)
[33]
Sanchez-Rangel E, Inzucchi S E. Metformin: Clinical Use in Type 2 Diabetes[J]. Diabetologia, 2017, 60(9):1586-1593.
doi: 10.1007/s00125-017-4336-x
pmid: 28770321
[34]
Fullerton B, Siebenhofer A, Jeitler K, et al. Short-acting Insulin Analogues Versus Regular Human Insulin for Adult, Non-pregnant Persons with Type 2 Diabetes Mellitus[J]. The Cochrane Database of Systematic Reviews, 2018, 12: CD013228.
[35]
Defronzo R A, Inzucchi S, Abdul-Ghani M, et al. Pioglitazone: The Forgotten, Cost-effective Cardioprotective Drug for Type 2 Diabetes[J]. Diabetes & Vascular Disease Research, 2019, 16(2):133-143.
[36]
Lee I M, Shiroma E J, Lobelo F, et al. Effect of Physical Inactivity on Major Non-Communicable Diseases Worldwide: An Analysis of Burden of Disease and Life Expectancy[J]. The Lancet, 2012, 380(9838):219-229.
doi: 10.1016/S0140-6736(12)61031-9